Production (Stage)
Aligos Therapeutics, Inc.
ALGS
$5.50
-$0.17-3.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 142.12% | -24.00% | -20.75% | -16.15% | -16.92% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.73% | 6.16% | -2.66% | -5.46% | -1.02% |
| Total Current Assets | 130.45% | -22.15% | -19.83% | -15.66% | -16.32% |
|
|
|||||
| Total Current Assets | 130.45% | -22.15% | -19.83% | -15.66% | -16.32% |
| Net Property, Plant & Equipment | -6.33% | -8.07% | -7.44% | -6.55% | -6.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.80% | -1.26% | 0.63% | 0.96% | 0.00% |
| Total Assets | 115.00% | -20.73% | -18.73% | -14.93% | -15.59% |
|
|
|||||
| Total Accounts Payable | 73.47% | -6.17% | -59.82% | 139.94% | 12.91% |
| Total Accrued Expenses | -29.29% | 9.86% | 17.38% | 0.17% | -28.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.84% | 1.71% | 1.34% | 2.47% | 1.08% |
| Total Finance Division Other Current Liabilities | -- | -76.95% | -50.60% | 83.91% | -44.88% |
| Total Other Current Liabilities | -- | -76.95% | -50.60% | 83.91% | -44.88% |
| Total Current Liabilities | -12.83% | 3.73% | -11.07% | 24.81% | -21.02% |
|
|
|||||
| Total Current Liabilities | -12.83% | 3.73% | -11.07% | 24.81% | -21.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.78% | -14.23% | -11.56% | -10.11% | -8.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -84.92% | 522.05% | 0.91% | -72.54% | 52.00% |
| Total Liabilities | -65.42% | 158.46% | -7.82% | -38.95% | 14.57% |
|
|
|||||
| Common Stock & APIC | 17.39% | 0.55% | 0.35% | 0.41% | 0.46% |
| Retained Earnings | 6.97% | -15.33% | -3.73% | 0.97% | -7.16% |
| Treasury Stock & Other | -0.89% | -21.84% | 16.80% | 3.78% | -12.66% |
| Total Common Equity | 501.91% | -157.83% | -25.48% | 12.43% | -35.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 501.91% | -157.83% | -25.48% | 12.43% | -35.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 501.91% | -157.83% | -25.48% | 12.43% | -35.06% |
|
|
|||||